Drug Profile
Dexverapamil
Alternative Names: d-VerapamilLatest Information Update: 29 Jan 2013
Price :
$50
*
At a glance
- Originator Abbott GmbH & Co. KG
- Class Chemosensitisers; Nitriles; Phenethylamines; Small molecules
- Mechanism of Action P-glycoprotein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 31 Jul 1997 Discontinued-I for Cancer in Japan (PO)
- 31 Jul 1997 Discontinued-II for Cancer in France (PO)
- 31 Jul 1997 Discontinued-II for Cancer in Italy (PO)